Scientific Programme Committee/Plenary Speaker
Marom Bikson, The City College of New York, NY, USA
Marom Bikson, is a Cattell Professor of Biomedical Engineering at The City College of New York (CCNY) of the City University of New York (CUNY) and co-Director of the Neural Engineering Group at the New York Center for Biomedical Engineering. The translational R&D activity of his group spans pre-clinical studies, computational models, device design and fabrication, regulatory activities, and clinical trials. Technologies developed by his group are in clinical trials in over 100 medical centers and include neuromodulation interventions for neuropsychiatric disorders, intra- and post-operative sensors, patient compliance tools, and surgeon training simulators. Dr. Bikson has published over 200 papers and book-chapters and is inventor on over 30 patent applications. He is known for his work on brain targeting with electrical stimulation, cellular physiology of electric effects, and electrical safety. Dr. Bikson co-invented High-Definition transcranial Direct Current Stimulation (HD-tDCS), the first non-invasive, targeted, and low-intensity neuromodulation technology. Dr. Bikson consults for medical technology companies and regulatory agencies on the design, validation, and certification of medical instrumentation. Dr. Bikson is co-founder of Soterix Medical Inc. and WiPOX LLC. Prior to becoming faculty at CUNY, Dr. Bikson was a research fellow at the University of Birmingham Medical School, UK and a Research Associate at Sontra Medical LLC, in Cambridge Mass. Dr. Bikson received a Ph.D. in Biomedical Engineering from Case Western Reserve University, in Cleveland OH, and a B.S. in Biomedical Engineering from Johns Hopkins University, Baltimore MD.